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Abstract
PilY1 is a type IV pilus (tfp)-associated protein from the opportunistic pathogen Pseudomonas aeruginosa that shares
functional similarity with related proteins in infectious Neisseria and Kingella species. Previous data have shown that PilY1
acts as a calcium-dependent pilus biogenesis factor necessary for twitching motility with a specific calcium binding site
located at amino acids 850–859 in the 1,163 residue protein. In addition to motility, PilY1 is also thought to play an
important role in the adhesion of P. aeruginosa tfp to host epithelial cells. Here, we show that PilY1 contains an integrin
binding arginine-glycine-aspartic acid (RGD) motif located at residues 619–621 in the PilY1 from the PAK strain of P.
aeruginosa; this motif is conserved in the PilY1s from the other P. aeruginosa strains of known sequence. We demonstrate
that purified PilY1 binds integrin in vitro in an RGD-dependent manner. Furthermore, we identify a second calcium binding
site (amino acids 600–608) located ten residues upstream of the RGD. Eliminating calcium binding from this site using a
D608A mutation abolished integrin binding; in contrast, a calcium binding mimic (D608K) preserved integrin binding.
Finally, we show that the previously established PilY1 calcium binding site at 851–859 also impacts the protein’s association
with integrin. Taken together, these data indicate that PilY1 binds to integrin in an RGD- and calcium-dependent manner in
vitro. As such, P. aeruginosa may employ these interactions to mediate host epithelial cell binding in vivo.
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Introduction
Pseudomonas aeruginosa is a Gram-negative, opportunistic patho-
gen prevalent in immunocompromised patients, burn victims, and
people with cystic fibrosis. P. aeruginosa can infect any part of the
body, buttypically targets the respiratory tissues, skinabrasions,and
the urinary tract [1]. This pathogen accounted for ,11% of the
hospital-acquired infections reported in the U.S in 2002 [2,3], and
has also been shown to infect other mammalian species, as well as
insects and plants [4,5]. P. aeruginosa uses a range of methods to resist
the effects of antibiotics, including efflux pumps, adaptive
mutagenesis, and protective biofilms [6,7,8]. As such, Pseudomonas
aeruginosa presents a significant challenge to human health.
P. aeruginosa employs type IV pili (tfp) for twitching motility and
infection. The precise mechanism of host cell attachment has
remained unclear, although evidence exists that loops of the major
pilus structural subunit PilA exposed at the tip of the pilus fiber
bind to gangliosides GM1 and GM2 [9]. In contrast, some data
indicate that several P. aeruginosa clinical isolates, as well as
laboratory strains, do not employ GM1 and GM2 during host cell
attachment [10,11]. As such, it has been proposed that other
factors on the Pseudomonas tfp are involved in binding to target cells
[12,13].
Recent studies have suggested that host cell integrin proteins
play a role in Pseudomonas infection. Anti-integrin antibodies were
shown to reduce P. aeruginosa attachment to host cells [14].
Specifically, antibodies to the aVb5 integrin and aVb3 integrin
were effective at disrupting P. aeruginosa binding to host cells, with
antibodies to aVb5 integrin having the most pronounced effect
[14]. Integrins are present on the epithelial cell surface of tissues
infected by P. aeruginosa; indeed, aVb5 integrin is highly expressed
in the lungs [15]. The presence of P. aeruginosa has also been shown
to increase the expression of integrin subunits aV, a5, and b1i n
epithelial cells [16,17]. Integrins and integrin-like proteins are
found widely in animals, plants, and insects, all targets of P.
aeruginosa infection [18]. Integrins are responsible for a range of
cellular processes, including cell-cell attachment, cellular signaling,
and angiogenesis [19]. The most common ligands for integrins are
proteins that contain an arginine-glycine-aspartic acid (RGD)
sequence, although other short peptides have also been found to
mediate integrin-protein interactions (e.g., leucine-aspartic acid-
valine or LDV).
The PilC class of proteins in Neisseria gonorrhoeae, Neisseria
meningitidis, and Kingella kingae have been characterized as tfp
biogenesis factors and as proteins involved in adhering to target
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e29629tissues [20,21,22]. Generally, PilC N-terminal regions are
associated with adhesion domains, while the C-terminal domains
regulate tfp biogenesis. P. aeruginosa PilY1 shares sequence
homology with the C-terminal regions of the PilCs proteins, and
this domain in PilY1 has been shown to be a calcium-mediated tfp
biogenesis factor (Table S1) [23]. Indeed, PilY1 is required for
both twitching and swarming motility and adhesion to host cells
[23,24,25]. The N-terminal domains of PilY1 and the PilCs share
low sequence similarity, which might be expected if these domains
are involved in target cell-specific activities. The target tissues of
the Neisseria strains and Kingella are likely to be distinct from those
targeted by P. aeruginosa. Here, we focus on putative regions of
PilY1 involved in host cell attachment and we show that purified
PilY1 binds to integrins in an RGD- and calcium-dependent
manner in vitro.
Results
PilY1 contains a conserved integrin binding motif
Given the importance of the tfp associated PilY1 protein in host
tissue adherence and the ability of antibodies targeting the RGD
binding domains of aVb5 and aVb3 integrins to reduce
interactions between P. aeruginosa and host cells, we examined
PilY1’s sequence to locate possible integrin binding motifs (RGD
or LDV) [14,25]. PilY1 was found to contain a conserved RGD
motif (Figure 1A, 1B). No other type IV pilus proteins or known
surface proteins in P. aeruginosa contained an RGD or other
putative integrin binding sequence [26,27]. One RGD motif was
found in each of the PilY1s of P. aeruginosa strains of known
sequence. For example, in the PilY1 from P. aeruginosa strain K
(PAK), the RGD is located at residues 619–621; however, in the
PAO1 P. aeruginosa strain PilY1, the RGD is at 657–659
(Figure 1B). Based on these observations, we hypothesized that
PilY1 binds to integrin in an RGD-dependent manner.
PilY1 binds integrin in an RGD-dependent manner
To test the hypothesis that PilY1’s RGD motif mediates
contacts with integrins, we created a purified form of PilY1 that
starts at amino acid 532 and extends to C-terminus of the protein
(residue 1163) and tested the ability of 532–1163 PilY1 to bind to
aVb5 using an integrin binding assay. Titration of increasing
concentrations of 532–1163 PilY1 showed that mid-nanomolar
concentrations of this purified protein binds specifically to aVb5
(Figure 2A). Next, we employed synthetic RGDS and GRADSP
peptides to compete with PilY1 binding to aVb5 integrin. We
found that that the RGDS peptide significantly reduced PilY1
binding to aVb5 integrin (p,0.10), while the GRADSP control
peptide had no effect (Figure 2B). Because previous reports also
indicated that PAK binding to host cells can be reduced by using
an anti-aVb3 integrin antibody, we also examined PilY1 binding
to aVb3. We found that purified 532–1163 PilY1 binds to aVb3
integrin in an RGD-dependent manner, although with a lower
apparent affinity than observed with aVb5 integrin (Figure 2C)
[14]. We therefore used aVb5 as the primary integrin of this study.
Finally, we tested two RGD mutants of 532–1163 PilY1, D621A
(RGA) and D619–621 (DRGD), for their ability to bind to aVb5
integrin in vitro. Deleting the RGD residues or mutating the
aspartic acid residue at position 621 to alanine significantly
Figure 1. P. aeruginosa PilY1 strains contain conserved integrin binding residues RGD and conserved putative calcium binding site.
(a) A bar representation of PilY1. The consensus c-terminal pilus biogenesis domain is in blue and the green represents the n-terminal addition to the
previously examined construct. Calcium binding motifs are highlighted in yellow and the RGD is highlighted in orange. (b) Five varying strains of P.
aeruginosa PilY1 were aligned using the biology workbench server [26,27]. Blue residues and an ‘‘*’’ corresponds to identical residues throughout the
5 strains, green residues and a ‘‘:’’ correspond to highly conserved residues, and navy residues and a ‘‘.’’ corresponds to mildly conserved residues (e.g.
alanine and leucine). Reference numbers are for PAK_287 PilY1 (the strain used in this study).
doi:10.1371/journal.pone.0029629.g001
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Importantly, these mutations did not alter the global secondary
structure or the melting temperature of purified 532–1163 PilY1
(Figure 2E, Table S2). Taken together, these data indicate that P.
aeruginosa PilY1 binds to integrins in vitro in an RGD-dependent
manner.
PilY1 has a second calcium binding site
A second potential calcium binding site was noted in the
sequence of P. aeruginosa PilY1 between residues 600 and 608,
which is in close proximity to the RGD motif (619–621) described
above (Figure 1A). Recall that a calcium binding site at residues
851–859 in PilY1 was shown in previous work to be critical to tfp
biogenesis and twitching motility [23]. The sequences of the two
calcium binding sites are closely related (Figure 3A), and the
putative 600–608 site is conserved in PilY1s of known sequence
(Figure 1B). Indeed, in the P. aeruginosa PilY1 sequences examined,
this second potential calcium binding site was always found 8–10
residues upstream of the conserved RGD motif (Figure 1B). To
test the 600–608 site’s ability to bind calcium in purified 532–1163
PilY1, we eliminated the previously published calcium binding site
using either a D859A or D859K mutation [23], and measured
calcium binding. The D859A and D859K forms of 532–1163
PilY1 exhibited Kd’s for calcium binding of 412 and 266 nM,
respectively (Figure 3B). Thus, the 600–608 site appeared to bind
calcium. We next created corresponding mutations (D608A,
D608K) in the 532–1163 PilY1 construct, and found that these
variants bound calcium with 2.3–2.4 mM affinity, similar to that
reported previously for the 851–859 PilY1 site (Figure 3C) [23].
Finally, we created a D608A/D859A double-mutant form of 532–
1163 PilY1 and compared its calcium binding to wild-type 532–
1163 PilY1. We found that the double-mutant exhibited only non-
specific calcium binding, while wild-type 532–1163 PilY1
associated with calcium with a 700 nM affinity (Figure 3D). The
variant forms of 532–1163 PilY1 examined in vitro in these studies
maintained an overall wild-type fold and melting temperature,
indicating that these changes did not alter the stability of the
proteins (Figure S1A–E; Table S2). Additionally, mutations in the
RGD sequence adjacent to the 600–608 site did not alter calcium
binding by these purified forms of 532–1163 PilY1 (Figure S2A).
The 532–1163 PilY1 construct demonstrated 1.3 mM and 600 nM
affinity binding to Zn and Mn, respectively, and non-specific
Figure 2. Purified PilY1 binds to integrin in an RGD dependent manner. (a) PilY1 was titrated onto a solid phase binding assay keeping the
concentration of aVb5 integrin constant at 2 mg/mL. The curve was fit to the ligand binding, one site saturation equation f=Bmax*abs(x)/(Kd+abs(x))
with an r
2=0.98. The Kd was calculated at 164 nM638. (b–d) Wild type PilY1 was established as a reference point and the value all measurements
were compared to. (b) RGDS inhibitor peptide or GRADSP control peptide were added in 2, 100, and 250 fold molar excess to PilY1. ‘‘*’’ corresponds to
p,.1 compared to PilY1 binding to aVb5 integrin. (c) PilY1 was added with or without 50 fold molar excess of the inhibitor RGDS peptide to 2 mg/mL
of aVb3 integrin. ‘‘**’’ corresponds to p,.02 compared to PilY1 binding to aVb3 integrin. (d) DRGD (D619–621) or D621A mutations of PilY1 were
added to 2 mg/mL of aVb5 integrin. ‘‘***’’ corresponds to p,.01 compared to PilY1 binding to aVb5 integrin. (e) Molar ellipticity values were
calculated for the respective wavelength scans and compared.
doi:10.1371/journal.pone.0029629.g002
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similarity to established calcium binding sites, we consider calcium
to be the primary metal bound to PilY1 [23,28,29,30]. Taken
together, these observations support the conclusion that purified
532–1163 PilY1 contains two calcium binding sites, the previously
characterized one at 851–859 and a newly identified one at 600–
608 that is ten residues N-terminal to PilY1’s RGD motif.
PilY1 binds integrin in a calcium dependent manner
Because the 600–608 calcium binding site in PilY1 is close in
sequence to the RGD motif, we next sought to examine whether
calcium binding impacted the association between 532–1163
PilY1 and integrin. We found that D859A, D859K, and D608K
mutant forms of 532–1163 PilY1 exhibit wild-type or only slightly
reduced binding to aVb5; in contrast, the D608A mutant of
purified PilY1 was significantly inhibited in its binding to this
integrin (Figure 4A). Thus, eliminating the charged D608 side
chain proximal to the RGD motif impacted PilY1’s interaction
with aVb5. We then examined double mutant forms of 532–1163
PilY1 and found that the two calcium binding sites interacted
functionally with respect to integrin binding (Figure 4B). For
example, the D608A/D859A variant of 532–1163 PilY1 shows
nearly wild-type levels of aVb5 binding (Figure 4B); recall that the
D608A form of PilY1 exhibited little integrin binding in vitro
(Figure 4A). Thus, D859A appears to act as a dominant positive
over the D608A mutation. Similarly, the D608K/D859A PilY1
shows increased integrin binding relatively to wild-type (Figure 4B).
In contrast, adding the D859K mutation to either D608A or
D608K in PilY1 had no impact on integrin binding relative to the
608 mutants alone (Figure 4B). Taken together, these data suggest
that both calcium binding sites in PilY1 impact integrin binding in
vitro. Note that the single- and double-mutants considered here did
not bind calcium (Figure S2B), and exhibited wild-type CD spectra
and melting temperatures (Figure S1A–E, Table S2), indicating
that the overall structure of these purified proteins was not altered.
The crystal structure of the C-terminal domain of PilY1 does
not contain the 600–621 region; as such, it is not known whether
the two calcium binding sites are in close structural proximity.
Figure 3. PilY1 has two functional calcium binding sites. (a) An alignment of the two calcium binding sites in PilY1 was performed as in
figure 1. Calcium coordinating residues are underlined. (b, c, and d) A calcium competition binding assay using Oregon Green was performed with (b)
D859A and D859K, (c) D608A and D608K, and (d) wild type and D608A/D859A. Binding curves were modeled to one-site competition (D859A, D859K,
D608A, D608K, and wild type), or linear line (D608A/D859A). Error represents standard error of the mean.
doi:10.1371/journal.pone.0029629.g003
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functional impact of one upon the other is via the swapping of an
aspartic acid from one site (e.g., D851 or D855) into the other site
(600–608). To test this hypothesis, we created two triple mutant
forms of 532–1163 PilY1, D608A/D851A/D859A and D608A/
D855A/D859A, and one quadruple mutant form, D608A/
D851A/D855A/D859A. Both triple mutants and the quadruple
mutant show wild type levels of binding (Figure S4). Thus, we
conclude that an interaction between the two calcium binding sites
in PilY1 is not primarily associated with aspartic acids in one site
helping to coordinate calcium in the other site. However, taken
together, these data indicated that a functional interaction
between the two calcium binding sites in PilY1 impacts the ability
of the RGD motif in this protein to bind to integrins in vitro.
Discussion
P. aeruginosa is an established and increasingly antibiotic resistant
pathogen that predominantly infects patients with compromised
defense mechanisms. Toward this end, we sought to understand
how P. aeruginosa binds to host cells, a necessary first step in
infection. We focused on the type IV pilus-associated protein
PilY1, which is involved in bacterial motility and is related in
sequence to factors in other bacteria required for host cell binding.
We show that PilY1 contains an integrin binding RGD motif that
mediates contact between purified PilY1 and integrin proteins in
vitro. Additionally, we show that PilY1 contains two calcium
binding sites and that each site impacts the protein’s ability to
associate with integrin (Figure 4C). Both the calcium binding sites
and the RGD motif are conserved in all PilY1 sequences from P.
aeruginosa strains reported to date (Figure 1B).
It was not anticipated that the PilY1 calcium binding sites,
particularly the one distal (851–859) to the RGD sequence, would
impact integrin binding. In fact, D859A can be seen as a dominant
positive with respect to integrin binding (Figure 4C). For example,
while the D608A mutant form of PilY1 is significantly reduced in
integrin binding, combining it with D859A to create a D608A/
D859A double-mutant produces a protein that is capable of
binding to integrin (Figure 4B). Further, a D608K/D859A double-
mutant exhibits higher integrin binding than either single mutant
or the wild-type protein (Figure 4B). In spite of these in vitro data,
however, the molecular contacts involved in these effects are not
clear, in part because the region between residues 600 and 643 in
PilY1 has not been elucidated structurally. It is tempting to
speculate that a physical association exists between the two
calcium binding sites that impacts RGD presentation for integrin
binding. Such speculation is supported by the data outlined here,
but remains speculation until future studies to examine the
structure of this region of PilY1 are complete.
Figure 4. Calcium binding sites play a role in PilY1’s ability binds to integrin. (a) D608A, D608K, D859A, D859K (b) D608A/D859A, D608A/
D859K, D608K/D859A, and D608K/D859K mutations of PilY1 were added to aVb5 integrin as seen in figure 2B. ‘‘*’’ corresponds to p,.01 compared to
wild type PilY1 binding to aVb5 integrin and ‘‘**’’ corresponds to p,.1 as compared to wild type PilY1 binding to aVb5 integrin. (c) This model
represents the calcium binding effects on PilY1 binding to integrin. D to A mutations represent mutations in the final aspartic acid of the calcium
binding site.
doi:10.1371/journal.pone.0029629.g004
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and the animal kingdom. They are up-regulated during cellular
stress and recovery [31,32,33]; indeed, the presence of P. aeruginosa
itself up-regulates the expression levels of the aV integrin subunit
[16]. In addition, integrins are established targets for bacterial
pathogens. Bordetella pertussis protein pertactin, containing two
RGD motifs, has been shown to adhere to Chinese hamster ovary
cells in an RGD-dependent manner [34,35]. Pertactin is a
member of the auto-transporter family, many of which contain
RGD motifs mediating adherence to integrins [36]. However,
there are conflicting data on whether auto-transporter RGDs are
relevant in mouse models of infection [37]. Still, other in vitro and
in vivo studies have shown that the following bacteria bind integrin
in an RGD-dependent manner: Pyrenophora tritici-repentis (a wheat
pathogen), Mycoplasma conjunctivae (sheep pathogen), and the
mammalian pathogens Klebsiella pneumoniae and Helicobacter pylori
[38,39,40]. Integrins are also known targets for viral pathogens.
Proteins in hepatitis C virus, coxsackievirus A9, human herpes
virus 8, Epstein-Barr virus, and adenovirus bind to host cells in an
RGD dependent manner [41,42,43,44,45]. In summary, integrins
have the potential to be important target proteins for PilY1-
mediated attachment of P. aeruginosa.
Interestingly, calcium has also been shown to play a vital role in
host RGD substrate:integrin binding events (Figure 5). Calcium
binding helps in the folding of the blood clotting factor fibrinogen,
and it protects against cleavage and degradation of the hemostasis
protein von Wildenbrand factor and the elastin scaffold protein
fibrillin (Figure 5) [46,47,48,49]. Some integrin substrates, such as
thrombospondin, use cooperative calcium binding at multiple sites
to facilitate integrin binding, while calcium increases adhesion in
tenascin, vitronectin, and osteopontin to target integrins (Figure 5)
[50,51,52,53,54]. Thus, there is precedent for calcium regulation
of RGD-mediated contacts with integrins.
PilY1 is an established pilus biogenesis factor [23] and has been
implicated in P. aeruginosa adhesion to host cells by functional
studies [25] and due to its homology to the PilCs adhesin proteins
of Neisseria [55]. Here, we provide evidence that PilY1 serves as an
adhesin that binds to integrins in an RGD-dependent manner.
Furthermore, we show that integrin binding is regulated by two
distinct calcium binding sites in PilY1. These data provide an in
vitro advance in our understanding of PilY1 structure and function.
It will be of interest to determine in future studies whether PilY1
and integrins are involved in P. aeruginosa attachment to host cells in
vivo.
Methods
PilY1 constructs and protein purification
Site-directed mutagenesis was performed to produce D608A,
D608K, D621A, D619–621, D859A, D859K, D608A/D859A,
D608A/D859K, D608K/D859A, D608K/D859K, D608A/
D851A/D859A, D608A/D855A/D859A, and D608A/D851A/
D855A/D859A mutants in a pDONR vector containing PilY1.
Amino acids 532–1163 were cloned out of the pDONR vector for
entry into pMCSG7 for protein expression. Vectors were
transformed into BL21 Gold (Stratagene) on ampicillin plates
overnight and a single colony was used to inoculate a 100 mL LB
flask overnight containing 50 mM/mL ampicillin. Cell cultures
were centrifuged at 30006g and the supernatant was discarded.
The resultant pellet was used to inoculate a 1.5 L shaker flask of
Terrific Broth with 50 mL of antifoam (Sigma-Aldrich) and
50 mM/mL ampicillin. Cells were grown at 37uC until OD600
reached 0.6–0.8. Temperature was reduced to 18uC and protein
expression was induced with 0.5 mM IPTG. Cells were grown
overnight and harvested by centrifugation 60006g at for
15 minutes at 4uC, and pellets were stored at 280uC.
Cells pellets were thawed using buffer consisting of 25 mM
HEPES pH 7.5, 150 mM NaCl, 10 mM imidazole, 5% glycerol,
DNase and protease inhibitor tablets (Roche). Cells were sonicated
and cell lysate was separated into soluble and insoluble fractions
using high-speed centrifugation. The soluble fraction was filtered
then nickel purified, buffer exchanged, and separated using an
S200 gel filtration column on an A ¨KTAxpress
TM (GE Health-
Care). If necessary, protein and storage buffers were chelated by
Chelex-100 to remove bound calcium (Bio-Rad Laboratories).
Purified proteins were concentrated to ,100 mM, frozen, and
stored at 280uC.
Integrin binding assay
Costar EIA/RIA stripwell high binding plates were coated with
either 2 mgo fp u r i f i e daVb5i n t e g r i no r2mgo fp u r i f i e daVb3
integrin (Millipore) for the experimental wells, or the molar
equivalent of BSA for the control wells, at 100 mL in 100 mM
sodium bicarbonate buffer pH 9.6 (Abcam) for 16 hours at 4uC.
Plateswerewashed16with300 mLofPBS.Wellswerethenblocked
with 1% BSA in PBS for one hour at room temperature. Plates were
washed 16with PBS and 100 mg/mL of PilY1 (Wild Type, D621A,
D619–621, D608A, D608K, D859A, D859K, D608A/D859A,
D608A/D859K, D608K/D859A, D608K/D859K, D608A/
Figure 5. Calcium effects on RGD binding proteins.
doi:10.1371/journal.pone.0029629.g005
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D855A/D859A) in binding buffer (50 mM Tris pH 7.8, 100 mM
NaCl2 mMCaCl2, 1 mMMgCl2,1 mMMnCl2, and 0.1% Triton)
wasaddedtoeachwellincludingtheBSAcontrolwellsfor6 hoursat
16uC with or without RGDS peptide (inhibitor), GRADSP peptide
(control), or no peptide. Metals are needed in the binding buffer for
integrin structural integrity. Plates were then washed 36with PBST
(0.1% Tween-20) and 36 with PBS before adding rabbit aPilY1
polyclonal antibody 1:500 per well in 1% BSA in PBS overnight for
16 hoursat4uC.Plateswerethenwashed3timeswithPBSTand36
with PBS before adding the Alexa fluor 488 f(ab9)2 fragment goat
anti-rabbit (Invitrogen) 1:5000 in 1% BSA in PBS protected from
light at room temperature for 1 hour. Plates were then washed 36
with PBST, 36 with PBS, then dried. Plates were read on a
PHERAstar (BMG LabTech). The experimental and control well
averages and standarderror of the mean(SEM) werecalculated, and
then the control average was subtracted from the experimental
values and the errors were compounded using the equation
!((experimental SEM)
2+(control SEM))
2.
Calcium binding assay
A binding curve for Oregon GreenH 488 BAPTA-5N,
hexapotassium salt (Invitrogen) in 25 mM HEPES pH 7.5,
250 mM NaCl, 10 mM imidazole, 5% glycerol was measured
on a PHERAstar (BMGLabtech) at 488 nm. 20 mM Oregon
Green, either 2 mM CaCl2,2mM MnCl2,o r2mM ZnCl2, and
PilY1 constructs were serial diluted 1.5–3 fold from ,100 mMt o
,1 nM to obtain an EC50 which was then used to calculate the
respective PilY1 Kd for calcium as described previously or PilY1
concentration was held constant and MgCl2 concentration was
titrated to determine if PilY1 had an affinity to magnesium [23].
Circular dichroism and thermal denaturation
Protein samples were buffer exchanged into chelated 10 mM
KxHxPO4 50 mM NaF pH 7.7 buffer and brought to 5 mM with
or without the addition of CaCl2. A wavelength scan from 200–
260 l was performed on a Circular Dichroism Spectrometer 62
DS (Aviv) at 16uC with a 10 second averaging time. Melting
temperatures were measures at l 214 from 3uCt o9 5 uC at one
degree increments with a 10 second averaging time.
Supporting Information
Figure S1 Circular dichroism for calcium binding
mutants. A–E Molar ellipticity values were calculated for the
respective wavelength scans and compared.
(TIFF)
Figure S2 PilY1 mutation binding curves. (a) DRGD and
R619A were modeled to one-site binding. (b) Double calcium
binding site mutants D608A/D859K, D608K/D859A, and
D608K/D859K. Error represents standard error of the mean.
(TIFF)
Figure S3 PilY1 alternate metal binding curves. (a)
Oregon Green binding curves were made by titrating magnesium
chloride, manganese chloride, or zinc chloride. Curves were fit to
one-site saturation (magnesium chloride and manganese chloride)
to determine Kd. (b,c) Zinc and mangansese curves were fit to one-
site binding. (d) Magnesium was titrated against Oregon Green,
calcium, and PilY1 at the Kd to determine affinity.
(TIFF)
Figure S4 Mutational effects on PilY1:Integrin binding.
As in Figure 2b–d, Wild type PilY1 was established as a reference
point and D608A/D851A/D859A, D608A/D855A/D859A, and
D608A/D851A/D855A/D859A were measured for integrin
binding.
(TIFF)
Table S1 P. aeruginosa PilY1 is homologous to PilC
family of bacterial adhesin and pilus biogenesis pro-
teins. PilY1 was individually aligned to K. Kingae (Kk) PilC1 and
PilC2, N. gonorrhea (Ng) PilC1 and PilC2, and N. meningitidis (Nm)
PilC1 and PilC2 using http://blast.ncbi.nlm.nih.gov/. C-terminal
homology indicates residues that are similar (e.g. leucine and
isoleucine) while c-terminal identity corresponds to identical
residues. Strains used for each protein are as follows: ACF19883
for Kingella kingae PilC1, ACF19886.1 for Kingella kingae PilC2,
O05924_NEIME for Neisseria meningitidis PilC1 O05925_NEIME
for Neisseria meningitidis PilC2, O05923_NEIGO for Neisseria
gonorrhea PilC1, and Q51019_NEIGO for Neisseria gonorrhea PilC2.
(TIFF)
Table S2 Melting temperatures (TM) for mutations of
PilY1. Proteins were scanned at 214 nm after an initial CD scan.
TMs were calculated using the standard three parameter sigmoidal
fit.
(TIFF)
Author Contributions
Conceived and designed the experiments: MDLJ JEB MRR. Performed
the experiments: MDLJ CKG. Analyzed the data: MDLJ JEB KAG MCW
MRR. Contributed reagents/materials/analysis tools: JEB KAG MCW.
Wrote the paper: MDLJ MRR.
References
1. Richards MJ, Edwards JR, Culver DH, Gaynes RP (1999) Nosocomial infections
in pediatric intensive care units in the United States. National Nosocomial
Infections Surveillance System. Pediatrics 103: e39.
2. Klevens RM, Edwards JR, Richards CL, Jr., Horan TC, Gaynes RP, et al.
(2007) Estimating health care-associated infections and deaths in U.S. hospitals,
2002. Public Health Rep 122: 160–166.
3. Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial
etiology of nosocomial infection. Am J Med 91: 72S–75S.
4. Apidianakis Y, Rahme LG (2009) Drosophila melanogaster as a model host for
studying Pseudomonas aeruginosa infection. Nat Protoc 4: 1285–1294.
5. Starkey M, Rahme LG (2009) Modeling Pseudomonas aeruginosa pathogenesis
in plant hosts. Nat Protoc 4: 117–124.
6. Hoiby N, Ciofu O, Bjarnsholt T (2010) Pseudomonas aeruginosa biofilms in
cystic fibrosis. Future Microbiol 5: 1663–1674.
7. Mah TF, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial
agents. Trends Microbiol 9: 34–39.
8. Poole K (2004) Efflux-mediated multiresistance in Gram-negative bacteria. Clin
Microbiol Infect 10: 12–26.
9. Craig L, Pique ME, Tainer JA (2004) Type IV pilus structure and bacterial
pathogenicity. Nat Rev Microbiol 2: 363–378.
10. Schroeder TH, Zaidi T, Pier GB (2001) Lack of adherence of clinical isolates of
Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells. Infect Immun 69:
719–729.
11. Emam A, Yu AR, Park HJ, Mahfoud R, Kus J, et al. (2006) Laboratory and
clinical Pseudomonas aeruginosa strains do not bind glycosphingolipids in vitro
or during type IV pili-mediated initial host cell attachment. Microbiology 152:
2789–2799.
12. Azghani AO, Idell S, Bains M, Hancock RE (2002) Pseudomonas aeruginosa
outer membrane protein F is an adhesin in bacterial binding to lung epithelial
cells in culture. Microb Pathog 33: 109–114.
13. Lillehoj EP, Kim BT, Kim KC (2002) Identification of Pseudomonas aeruginosa
flagellin as an adhesin for Muc1 mucin. Am J Physiol Lung Cell Mol Physiol
282: L751–756.
14. Leroy-Dudal J, Gagniere H, Cossard E, Carreiras F, Di Martino P (2004) Role
of alphavbeta5 integrins and vitronectin in Pseudomonas aeruginosa PAK
interaction with A549 respiratory cells. Microbes Infect 6: 875–881.
P. aeruginosa PilY1 Binds Integrin
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e2962915. Goldman MJ, Wilson JM (1995) Expression of alpha v beta 5 integrin is
necessary for efficient adenovirus-mediated gene transfer in the human airway.
J Virol 69: 5951–5958.
16. Gravelle S, Barnes R, Hawdon N, Shewchuk L, Eibl J, et al. (2010) Up-
regulation of integrin expression in lung adenocarcinoma cells caused by
bacterial infection: in vitro study. Innate Immun 16: 14–26.
17. Humphries JD, Byron A, Humphries MJ (2006) Integrin ligands at a glance.
Journal of cell science 119: 3901–3903.
18. Swatzell LJ, Edelmann RE, Makaroff CA, Kiss JZ (1999) Integrin-like proteins
are localized to plasma membrane fractions, not plastids, in Arabidopsis. Plant
Cell Physiol 40: 173–183.
19. Sheppard D (2004) Roles of alphav integrins in vascular biology and pulmonary
pathology. Curr Opin Cell Biol 16: 552–557.
20. Nassif X, Beretti JL, Lowy J, Stenberg P, O’Gaora P, et al. (1994) Roles of pilin
and PilC in adhesion of Neisseria meningitidis to human epithelial and
endothelial cells. Proc Natl Acad Sci U S A 91: 3769–3773.
21. Kallstrom H, Liszewski MK, Atkinson JP, Jonsson AB (1997) Membrane
cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic
Neisseria. Mol Microbiol 25: 639–647.
22. Kirchner M, Heuer D, Meyer TF (2005) CD46-independent binding of
neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial
cells. Infect Immun 73: 3072–3082.
23. Orans J, Johnson MD, Coggan KA, Sperlazza JR, Heiniger RW, et al. (2010)
Crystal structure analysis reveals Pseudomonas PilY1 as an essential calcium-
dependent regulator of bacterial surface motility. Proc Natl Acad Sci U S A 107:
1065–1070.
24. Kuchma SL, Ballok AE, Merritt JH, Hammond JH, Lu W, et al. (2010) Cyclic-
di-GMP-mediated repression of swarming motility by Pseudomonas aeruginosa:
the pilY1 gene and its impact on surface-associated behaviors. Journal of
bacteriology 192: 2950–2964.
25. Heiniger RW, Winther-Larsen HC, Pickles RJ, Koomey M, Wolfgang MC
(2010) Infection of human mucosal tissue by Pseudomonas aeruginosa requires
sequential and mutually dependent virulence factors and a novel pilus-associated
adhesin. Cell Microbiol 12: 1158–1173.
26. Higgins DG, Bleasby AJ, Fuchs R (1992) CLUSTAL V: improved software for
multiple sequence alignment. Comput Appl Biosci 8: 189–191.
27. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through sequence
weighting, position-specific gap penalties and weight matrix choice. Nucleic
Acids Res 22: 4673–4680.
28. Rigden DJ, Galperin MY (2004) The DxDxDG motif for calcium binding:
multiple structural contexts and implications for evolution. J Mol Biol 343:
971–984.
29. Chattopadhyaya R, Meador WE, Means AR, Quiocho FA (1992) Calmodulin
structure refined at 1.7 A resolution. J Mol Biol 228: 1177–1192.
30. Weber C, Lee VD, Chazin WJ, Huang B (1994) High level expression in
Escherichia coli and characterization of the EF-hand calcium-binding protein
caltractin. J Biol Chem 269: 15795–15802.
31. Cass DL, Bullard KM, Sylvester KG, Yang EY, Sheppard D, et al. (1998)
Epidermal integrin expression is upregulated rapidly in human fetal wound
repair. J Pediatr Surg 33: 312–316.
32. Pilewski JM, Latoche JD, Arcasoy SM, Albelda SM (1997) Expression of integrin
cell adhesion receptors during human airway epithelial repair in vivo.
Am J Physiol 273: L256–263.
33. Saalbach A, Haupt B, Pierer M, Haustein UF, Herrmann K (1997) In vitro
analysis of adhesion molecule expression and gel contraction of human
granulation fibroblasts. Wound Repair Regen 5: 69–76.
34. Leininger E, Roberts M, Kenimer JG, Charles IG, Fairweather N, et al. (1991)
Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that
promotes adherence of mammalian cells. Proc Natl Acad Sci U S A 88:
345–349.
35. Leininger E, Ewanowich CA, Bhargava A, Peppler MS, Kenimer JG, et al.
(1992) Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella
pertussis adhesins pertactin and filamentous hemagglutinin. Infect Immun 60:
2380–2385.
36. Henderson IR, Navarro-Garcia F, Nataro JP (1998) The great escape: structure
and function of the autotransporter proteins. Trends Microbiol 6: 370–378.
37. Julio SM, Inatsuka CS, Mazar J, Dieterich C, Relman DA, et al. (2009) Natural-
host animal models indicate functional interchangeability between the
filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchisep-
tica and reveal a role for the mature C-terminal domain, but not the RGD motif,
during infection. Mol Microbiol 71: 1574–1590.
38. Manning VA, Hamilton SM, Karplus PA, Ciuffetti LM (2008) The Arg-Gly-
Asp-containing, solvent-exposed loop of Ptr ToxA is required for internalization.
Mol Plant Microbe Interact 21: 315–325.
39. Huang YJ, Wu CC, Chen MC, Fung CP, Peng HL (2006) Characterization of
the type 3 fimbriae with different MrkD adhesins: possible role of the MrkD
containing an RGD motif. Biochem Biophys Res Commun 350: 537–542.
40. Zimmermann L, Peterhans E, Frey J (2010) RGD motif of lipoprotein T,
involved in adhesion of Mycoplasma conjunctivae to lamb synovial tissue cells.
Journal of bacteriology 192: 3773–3779.
41. Nemerow GR, Stewart PL (1999) Role of alpha(v) integrins in adenovirus cell
entry and gene delivery. Microbiol Mol Biol Rev 63: 725–734.
42. Wang FZ, Akula SM, Sharma-Walia N, Zeng L, Chandran B (2003) Human
herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD
sequence. J Virol 77: 3131–3147.
43. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM (2008) The Epstein-Barr
virus BMRF-2 protein facilitates virus attachment to oral epithelial cells.
Virology 370: 430–442.
44. Chintakuntlawar AV, Zhou X, Rajaiya J, Chodosh J (2010) Viral capsid is a
pathogen-associated molecular pattern in adenovirus keratitis. PLoS Pathog 6:
e1000841.
45. Harvala H, Kalimo H, Stanway G, Hyypia T (2003) Pathogenesis of
coxsackievirus A9 in mice: role of the viral arginine-glycine-aspartic acid motif.
J Gen Virol 84: 2375–2379.
46. Amphlett GW, Hrinda ME (1983) The binding of calcium to human fibronectin.
Biochem Biophys Res Commun 111: 1045–1053.
47. Mihalyi E (2004) Review of some unusual effects of calcium binding to
fibrinogen. Biophys Chem 112: 131–140.
48. Reinhardt DP, Ono RN, Sakai LY (1997) Calcium stabilizes fibrillin-1 against
proteolytic degradation. J Biol Chem 272: 1231–1236.
49. Harfenist EJ, Packham MA, Kinlough-Rathbone RL, Cattaneo M, Mustard JF
(1987) Effect of calcium ion concentration on the ability of fibrinogen and von
Willebrand factor to support the ADP-induced aggregation of human platelets.
Blood 70: 827–831.
50. Lawler J, Weinstein R, Hynes RO (1988) Cell attachment to thrombospondin:
the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 107:
2351–2361.
51. Fusi FM, Bernocchi N, Ferrari A, Bronson RA (1996) Is vitronectin the velcro
that binds the gametes together? Mol Hum Reprod 2: 859–866.
52. He B, Mirza M, Weber GF (2006) An osteopontin splice variant induces
anchorage independence in human breast cancer cells. Oncogene 25:
2192–2202.
53. Singh K, Deonarine D, Shanmugam V, Senger DR, Mukherjee AB, et al. (1993)
Calcium-binding properties of osteopontin derived from non-osteogenic sources.
J Biochem 114: 702–707.
54. Slater M, Murphy CR, Barden JA (2002) Tenascin, E-cadherin and P2X
calcium channel receptor expression is increased during rat blastocyst
implantation. Histochem J 34: 13–19.
55. Mattick JS (2002) Type IV pili and twitching motility. Annu Rev Microbiol 56:
289–314.
P. aeruginosa PilY1 Binds Integrin
PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e29629